TAF (Tenofovir Alafenamide) for Preventing Progression of Liver Disease in Non-cirrhotic Chronic HBV Infection With Normal ALT and Low Viral Load.

Abroad (travel likely)Recruiting

Conditions

Non-cirrhotic, Chronic Hepatitis B

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Institute of Liver & Biliary Sciences (ILBS), New Delhi, National Capital Territory of Delhi, India

    Contact: Study coordinator (Dr Ankur Jindal, DM) · ankur.jindal3@gmail.com · 01146300000